Realbotix (XBOT.F) Q4 2024 earnings summary

Executive summary

• Achieved significant global media exposure at CES 2024 and CES 2025, with over 4 billion media impressions and strong interest from major technology companies and corporations across various industries.

• Fiscal year 2024 revenue rose 378% year-over-year to $1.3 million, reflecting growth, the Simulacra acquisition, and product launches.

• Transitioned focus to AI and robotics, rebranding as Realbotix and expanding the board in July 2024.

• Experiencing rapid growth in corporate inquiries and orders, primarily from large organizations rather than individuals.

• Management is optimistic about market size and future growth, citing overwhelming demand and positive feedback.

Financial highlights

• Q1 2024 revenue nearly matched the entire previous year's revenue, with FY-2024 revenue at $1.3 million, up from $268k in FY-2023.

• Net loss narrowed to $8.7 million from $10.1 million, impacted by $9.3 million in non-cash impairments.

• Company holds approximately CAD 9.7–10 million in cash and digital assets as of September 30, 2024; ETH holdings up 31% since year-end.

• Incurred a non-cash impairment of $9.3 million, primarily due to write-downs of intangibles and technology assets.

• Received $927,300 and 216.6 ETH from Genesis, representing 74% of ETH and 37% of SOL claims.

Outlook and guidance

• Management expects 2024 to be significantly better than 2023, but does not provide formal revenue or earnings guidance due to market unpredictability.

• Internal forecasts suggest a larger-than-anticipated market post-CES, with ongoing efforts to scale production and sales.

• AWS subsidy of $100,000 expected in Q1-2025 to support next-gen robotic controller and AI development.

• Plans to expand sales and marketing teams, explore uplisting to a U.S. exchange, and be more assertive in 2025 with domain name sales, including listing Tokens.com for $6 million.

• Ongoing optimism about cryptocurrency market and strategic ETH staking/sales.